latest news in companies

Ardent Health Facing Class Action Lawsuit After Stock Plunges 33%

Ardent Health Facing Class Action Lawsuit After Stock Plunges 33%

New York, Friday, 16 January 2026.
Investors face a critical March 9 deadline to join a securities fraud lawsuit against Ardent Health. The complaint alleges the company concealed failing revenue collection processes behind misleading accounting practices, triggering a massive sell-off that erased a third of the stock’s value overnight.

Denny's Enters Private Ownership Era Following $620 Million Acquisition

Denny's Enters Private Ownership Era Following $620 Million Acquisition

Spartanburg, Friday, 16 January 2026.
Denny’s Corporation officially exited the public market today, January 16, 2026, finalizing a $620 million acquisition by a consortium led by TriArtisan Capital Advisors. In a strategic pivot designed to revitalize the iconic brand away from public scrutiny, shareholders received $6.25 per share—a notable 52.1% premium over the pre-announcement closing price. This transaction places the 1,500-unit chain under private control, empowering leadership to aggressively pursue growth initiatives and capital reallocation without the pressure of quarterly public reporting.

Genmab’s Epcoritamab Outperforms Standard Care in Pivotal Phase 3 Lymphoma Trial

Genmab’s Epcoritamab Outperforms Standard Care in Pivotal Phase 3 Lymphoma Trial

Copenhagen, Friday, 16 January 2026.
Epcoritamab becomes the first bispecific antibody monotherapy to demonstrate improved progression-free survival in refractory large B-cell lymphoma, reducing progression risk by 26% versus standard chemotherapy.

Soleno Therapeutics Faces Investigation After Disappointing Drug Launch Metrics

Soleno Therapeutics Faces Investigation After Disappointing Drug Launch Metrics

Redwood City, Friday, 16 January 2026.
Soleno shares plummeted following allegations of misleading VYKAT XR launch metrics. Investigations now probe claims that data was manipulated by a controversial physician, raising serious concerns for investors.

Widespread Service Outage Disrupts Platform X Globally

Widespread Service Outage Disrupts Platform X Globally

San Francisco, Friday, 16 January 2026.
Tens of thousands of users worldwide lost access to X on Friday. This marks the platform’s second significant infrastructure failure in less than a week, disrupting critical real-time communication.

Gevo Targets Carbon Market Growth with Strategic Leadership Change

Gevo Targets Carbon Market Growth with Strategic Leadership Change

Englewood, Friday, 16 January 2026.
Gevo appoints Alex Clayton as Chief Carbon Officer to monetize its North Dakota facility, the only project currently issuing carbon credits with validated thousand-year permanence.

Nasdaq Private Market Valuation Quadruples in Latest Funding Round

Nasdaq Private Market Valuation Quadruples in Latest Funding Round

New York, Friday, 16 January 2026.
Securing a massive fourfold valuation jump since 2024, Nasdaq Private Market closed its Series C round today, underscoring the surging demand for liquidity and infrastructure in private equity.

Prediction Markets Challenge Sportsbooks by Adopting High-Reward Multi-Bet Features

Prediction Markets Challenge Sportsbooks by Adopting High-Reward Multi-Bet Features

New York, Friday, 16 January 2026.
Kalshi and Polymarket are aggressively adopting parlay features to rival traditional sportsbooks, with Kalshi’s new “combos” generating over $100 million in weekly trading volume alone.

EHang Promotes Founding Member Shuai Feng to Chief Technology Officer to Lead Commercial Push

EHang Promotes Founding Member Shuai Feng to Chief Technology Officer to Lead Commercial Push

Guangzhou, Friday, 16 January 2026.
Founding member Shuai Feng becomes EHang CTO to drive commercialization. Feng notably led the development of the EH216-S, the world’s first certified pilotless eVTOL, signaling a shift toward industrial scaling.

Barclays Lowers Atmos Energy Target to $165 as Analysts Diverge on Valuation

Barclays Lowers Atmos Energy Target to $165 as Analysts Diverge on Valuation

Dallas, Friday, 16 January 2026.
Diverging from recent optimism by Citigroup, Barclays lowered its target for Atmos Energy to $165, highlighting growing caution around the utility’s capital expenditure and valuation.